(MedPage Today) — Use of neoadjuvant or perioperative immunotherapy in combination with chemotherapy has proven effective for some patients with non-small cell lung cancer (NSCLC), but its role in patients with EGFR- or ALK-mutated disease is…
Source link : https://www.medpagetoday.com/spotlight/asco-nsclc/116781
Author :
Publish date : 2025-08-01 14:21:00
Copyright for syndicated content belongs to the linked Source.
